Description
ITOCAB, powered by Itraconazole 100/200 mg, is a highly effective antifungal therapy designed to eliminate deep-seated and persistent fungal infections. As a potent orally active antifungal agent, it targets a wide range of dermatophyte infections including Athlete’s Foot, Jock Itch, and Scalp Infections. ITOCAB is recommended as a first-line treatment for sporotrichosis and is equally effective in managing systemic fungal infections such as Blastomycosis, Histoplasmosis, Aspergillosis, and Onychomycosis. Its strong safety profile makes it suitable for long-term or maintenance therapy to prevent recurrence, ensuring complete recovery and protection. ITOCAB has demonstrated efficacy comparable to advanced antifungals like Posaconazole and Fluconazole, particularly in pediatric patients. It is also beneficial in treating refractory infections not responding to amphotericin B, offering reliable, comprehensive fungal control.
